INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
The insulin formerly derived from animal sources such as bovine, porcine and bovine-porcine has been replaced by human insulin and its equivalents. Structurally modified synthetic versions of these are created. These come from a variety of sources, mainly human insulin analogs. The only difference between human insulin and similar substances is the duration of action. For example, in the US only similar insulin is used and commercially available bovine and porcine insulin is not. Absorption, potency, and duration of action will change as a result of these changes. Similar to the first phase of insulin release, these forms are observed to achieve rapid pharmacodynamics and pharmacokinetics (ADME). These analogs work by mimicking the typical physiology of insulin. These are also believed to aid in postprandial glycemic management. Physiological and anatomical impairments are the early diagnostic features of Alzheimer's disease. These are now understood to be a crucial part of the pathogenesis of Alzheimer's disease. The sensitizer offers comfort and support for ideas that have been established in animal models of amyloidosis, such as B. An abnormal production can lead to insulin resistance, which contributes to a variety of cognitive disorders. Brain injury stimulates the production of A and causes insulin resistance, which is then alleviated by the sensitizer. The focus of this review is on insulin medicine, molecular mechanisms, and all aspects of memory related to Alzheimer's disease.
Keywords:
Insulin Analogues, Human Insulin, Insulin administration, and Hyperkalaemia.
Cite Article:
"INSULIN DRUGS AND THEIR ASSOCIATION WITH ALZHEIMER'S DISEASE", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 4, page no.g155-g165, April-2023, Available :http://www.ijnrd.org/papers/IJNRD2304621.pdf
Downloads:
000118755
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn